130 related articles for article (PubMed ID: 37574029)
1. Linezolid dosing in critically ill patients undergoing various modalities of renal replacement therapy: a pooled population pharmacokinetic analysis.
Liu Q; Li S; Xie F
Int J Antimicrob Agents; 2023 Oct; 62(4):106949. PubMed ID: 37574029
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment.
Barrasa H; Soraluce A; Isla A; Martín A; Maynar J; Canut A; Sánchez-Izquierdo JA; Rodríguez-Gascón A
J Crit Care; 2019 Apr; 50():69-76. PubMed ID: 30496913
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics and probability of target attainment in patients with sepsis under renal replacement therapy receiving continuous infusion of meropenem: Sustained low-efficiency dialysis and continuous veno-venous haemodialysis.
Westermann I; Gastine S; Müller C; Rudolph W; Peters F; Bloos F; Pletz M; Hagel S
Br J Clin Pharmacol; 2021 Nov; 87(11):4293-4303. PubMed ID: 33818823
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
He S; Cheng Z; Xie F
Drug Des Devel Ther; 2022; 16():13-22. PubMed ID: 35023902
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic/pharmacodynamic evaluations of amikacin dosing in critically ill patients undergoing continuous venovenous hemodiafiltration.
Li S; Zhu S; Xie F
J Pharm Pharmacol; 2023 Apr; 75(4):515-522. PubMed ID: 36847263
[TBL] [Abstract][Full Text] [Related]
6. Evaluating linezolid dose regimens against methicillin-resistant Staphylococcus aureus based on renal function in populations with different body weight.
Zuo M; Sun Y; Zhao X; Xu G; Wang N; Chen J; Zhu L; Yang W; Zhao M
J Clin Pharm Ther; 2022 Dec; 47(12):2162-2169. PubMed ID: 36053892
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of Linezolid Dose Adjustment for Creatinine Clearance in Critically Ill Patients: A Multicenter, Prospective, Open-Label, Observational Study.
Wang X; Wang Y; Yao F; Chen S; Hou Y; Zheng Z; Luo J; Qiu B; Li Z; Wang Y; Wu Z; Lan J; Chen C
Drug Des Devel Ther; 2021; 15():2129-2141. PubMed ID: 34040351
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetic Meta-Analysis and Dosing Recommendation for Meropenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
Peng Y; Cheng Z; Xie F
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0082222. PubMed ID: 36005753
[TBL] [Abstract][Full Text] [Related]
9. Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation.
Soraluce A; Barrasa H; Asín-Prieto E; Sánchez-Izquierdo JÁ; Maynar J; Isla A; Rodríguez-Gascón A
Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31936614
[TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetics and Dosage Optimization of Linezolid in Critically Ill Pediatric Patients.
Yang M; Zhao L; Wang X; Sun C; Gao H; Wang X; Qian S
Antimicrob Agents Chemother; 2023 May; 95(5):. PubMed ID: 33558298
[TBL] [Abstract][Full Text] [Related]
11. Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.
Minichmayr IK; Schaeftlein A; Kuti JL; Zeitlinger M; Kloft C
Clin Pharmacokinet; 2017 Jun; 56(6):617-633. PubMed ID: 27753002
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Linezolid Pharmacokinetics in Critically Ill Obese Patients with Severe Skin and Soft Tissue Infections.
Blackman AL; Jarugula P; Nicolau DP; Chui SH; Joshi M; Heil EL; Gopalakrishnan M
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33257446
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic/pharmacodynamic evaluation of linezolid for the treatment of staphylococcal infections in critically ill patients.
Dong H; Xie J; Wang T; Chen L; Zeng X; Sun J; Wang X; Dong Y
Int J Antimicrob Agents; 2016 Sep; 48(3):259-64. PubMed ID: 27474469
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics and target attainment analysis of linezolid in multidrug-resistant tuberculosis patients.
Tietjen AK; Kroemer N; Cattaneo D; Baldelli S; Wicha SG
Br J Clin Pharmacol; 2022 Feb; 88(4):1835-1844. PubMed ID: 34622478
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis.
Chen CY; Xie M; Gong J; Yu N; Wei R; Lei LL; Zhao SM; Li RM; Dong X; Zhang XL; Zhou Y; Li SL; Cui YM
Front Pharmacol; 2023; 14():1132367. PubMed ID: 37188268
[No Abstract] [Full Text] [Related]
17. Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study.
Ehmann L; Zoller M; Minichmayr IK; Scharf C; Maier B; Schmitt MV; Hartung N; Huisinga W; Vogeser M; Frey L; Zander J; Kloft C
Crit Care; 2017 Oct; 21(1):263. PubMed ID: 29058601
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study.
Braune S; König C; Roberts JA; Nierhaus A; Steinmetz O; Baehr M; Kluge S; Langebrake C
Crit Care; 2018 Jan; 22(1):25. PubMed ID: 29382394
[TBL] [Abstract][Full Text] [Related]
19. Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
Lewis SJ; Kays MB; Mueller BA
J Clin Pharmacol; 2016 Oct; 56(10):1277-87. PubMed ID: 26919659
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic/pharmacodynamic-guided gentamicin dosing in critically ill patients: a revisit of the Hartford nomogram.
He S; Cheng Z; Xie F
Int J Antimicrob Agents; 2022 Jun; 59(6):106600. PubMed ID: 35533792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
